लोड हो रहा है...
Development of an Effective Therapy for CML
Targeted small molecule drugs have revolutionized treatment of chronic myeloid leukemia (CML) over the last decade. These agents interrupt a constitutively active BCR-ABL, the causative agent for CML, by interfering with ATP-dependent ABL tyrosine kinase. Although the efficacy of tyrosine kinase inh...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
2011
|
| विषय: | |
| ऑनलाइन पहुंच: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3251313/ https://ncbi.nlm.nih.gov/pubmed/22157291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e318237e5b7 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|